Athersys, Inc. (ATHXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 10, 16:00
Athersys Gross Profit (TTM)
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -0.929M |
| June 30, 2023 | -0.004M |
| March 31, 2023 | 2.088M |
| December 31, 2022 | 4.805M |
| September 30, 2022 | 5.19M |
| June 30, 2022 | 5.242M |
| March 31, 2022 | 2.421M |
| December 31, 2021 | -0.488M |
| September 30, 2021 | -0.967M |
| June 30, 2021 | -0.967M |
| March 31, 2021 | -0.244M |
| December 31, 2020 | -0.19M |
| September 30, 2020 | -0.19M |
| June 30, 2020 | -0.19M |
| March 31, 2020 | -0.19M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.222M |
| March 31, 2018 | 0.222M |
| December 31, 2017 | 0.222M |
| September 30, 2017 | 0.222M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.147M |
| June 30, 2015 | 0.147M |
| March 31, 2015 | 0.147M |
| December 31, 2014 | 0.147M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 2.205M |
| June 30, 2013 | 2.205M |
| March 31, 2013 | 2.205M |
| December 31, 2012 | -0.692M |
| September 30, 2012 | -5.978M |
| June 30, 2012 | -5.978M |
| March 31, 2012 | -3.61M |
| December 31, 2011 | -0.713M |
| September 30, 2011 | 2.368M |
| June 30, 2011 | 2.368M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |
| Anixa Biosciences, Inc. | -0.039M |